Jean-Nicolas Vauthey

Closest collaborators

The 25 strongest of 61 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

1. Matthew H. G. Katz · 26 shared papers, 2012–2023
   • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
   • Paper AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatme… DOI 10.1016/j.suronc.2021.101673↗
   • Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
2. Jeffrey E. Lee · 26 shared papers, 2012–2023
   • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
   • Paper AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatme… DOI 10.1016/j.suronc.2021.101673↗
   • Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
3. Ching-Wei David Tzeng · 14 shared papers, 2012–2023
   • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
   • Paper AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatme… DOI 10.1016/j.suronc.2021.101673↗
   • Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
4. Michael Paul Kim · 11 shared papers, 2016–2023
   • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
   • Paper AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatme… DOI 10.1016/j.suronc.2021.101673↗
   • Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
5. Jason B. Fleming · 19 shared papers, 2012–2019
   • Paper Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Ident… DOI 10.1016/j.hpb.2018.10.018↗
   • Paper Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with… DOI 10.1002/jso.25067↗
   • Paper Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal A… DOI 10.1001/jamasurg.2017.2227↗
6. Laura R. Prakash · 7 shared papers, 2016–2022
   • Paper AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatme… DOI 10.1016/j.suronc.2021.101673↗
   • Paper Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenoca… DOI 10.1016/j.hpb.2018.10.009↗
   • Paper Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Ident… DOI 10.1016/j.hpb.2018.10.018↗
7. Gauri Rajani Varadhachary · 13 shared papers, 2012–2019
   • Paper Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Aden… DOI 10.1097/mpa.0000000000001345↗
   • Paper Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal A… DOI 10.1001/jamasurg.2017.2227↗
   • Paper Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. DOI 10.1007/s11605-016-3286-9↗
8. Robert A. Wolff · 12 shared papers, 2012–2017
   • Paper Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal A… DOI 10.1001/jamasurg.2017.2227↗
   • Paper Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. DOI 10.1007/s11605-016-3286-9↗
   • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
9. Peter W. T. Pisters · 12 shared papers, 2012–2015
   • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
   • Paper Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable an… DOI 10.1007/s11605-013-2374-3↗
   • Paper Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline rese… DOI 10.1111/hpb.12154↗
10. Huamin Wang · 10 shared papers, 2012–2017
    • Paper Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal A… DOI 10.1001/jamasurg.2017.2227↗
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
    • Paper Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable an… DOI 10.1007/s11605-013-2374-3↗
11. Christopher H. Crane · 10 shared papers, 2012–2016
    • Paper Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. DOI 10.1007/s11605-016-3286-9↗
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
    • Paper Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable an… DOI 10.1007/s11605-013-2374-3↗
12. Timothy Eric Newhook · 2 shared papers, 2022–2023
    • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
    • Paper AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatme… DOI 10.1016/j.suronc.2021.101673↗
13. Naruhiko Ikoma · 2 shared papers, 2022–2023
    • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
    • Paper AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatme… DOI 10.1016/j.suronc.2021.101673↗
14. David R. Fogelman · 6 shared papers, 2012–2019
    • Paper Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Aden… DOI 10.1097/mpa.0000000000001345↗
    • Paper Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal A… DOI 10.1001/jamasurg.2017.2227↗
    • Paper Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. DOI 10.1007/s11605-016-3286-9↗
15. Yun Shin Chun · 2 shared papers, 2019–2023
    • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
    • Paper Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma. DOI 10.1245/s10434-018-07093-x↗
16. Hop S. Tran Cao · 3 shared papers, 2014–2023
    • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
    • Paper Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable an… DOI 10.1007/s11605-013-2374-3↗
    • Paper Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on mult… DOI 10.1007/s11605-013-2412-1↗
17. Graciela M. Nogueras-González · 4 shared papers, 2012–2019
    • Paper Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Ident… DOI 10.1016/j.hpb.2018.10.018↗
    • Paper Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with… DOI 10.1002/jso.25067↗
    • Paper Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable an… DOI 10.1007/s11605-013-2374-3↗
18. James L. Abbruzzese · 7 shared papers, 2012–2014
    • Paper Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on mult… DOI 10.1007/s11605-013-2412-1↗
    • Paper Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first … DOI 10.1016/j.jamcollsurg.2012.03.024↗
    • Paper Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenoc… DOI 10.1002/cncr.26651↗
19. Ève Simoneau · 2 shared papers, 2019
    • Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗
    • Paper Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma. DOI 10.1245/s10434-018-07093-x↗
20. Jordan M. Cloyd · 3 shared papers, 2016–2019
    • Paper Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensit… DOI 10.1097/mpa.0000000000001231↗
    • Paper Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal A… DOI 10.1001/jamasurg.2017.2227↗
    • Paper Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. DOI 10.1007/s11605-016-3286-9↗
21. Yongwoo David Seo · 1 shared paper, 2023
    • Paper Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. DOI 10.1002/jhbp.1218↗
22. Aparna Balachandran · 5 shared papers, 2012–2015
    • Paper Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic … DOI 10.1245/s10434-014-4285-2↗
    • Paper Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline rese… DOI 10.1111/hpb.12154↗
    • Paper Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenoc… DOI 10.1245/s10434-011-2211-4↗
23. Federico Oppliger Boettcher · 1 shared paper, 2022
    • Paper AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatme… DOI 10.1016/j.suronc.2021.101673↗
24. Douglas B. Evans · 4 shared papers, 2012–2015
    • Paper Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic … DOI 10.1245/s10434-014-4285-2↗
    • Paper Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable an… DOI 10.1007/s11605-013-2374-3↗
    • Paper Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on mult… DOI 10.1007/s11605-013-2412-1↗
25. Andrew H. Lee · 1 shared paper, 2019
    • Paper Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoa… DOI 10.1016/j.hpb.2019.01.011↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.